SARRECCHIA, CESARE
 Distribuzione geografica
Continente #
NA - Nord America 10.693
EU - Europa 953
AS - Asia 583
SA - Sud America 61
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 12.300
Nazione #
US - Stati Uniti d'America 10.686
SG - Singapore 318
IT - Italia 171
CN - Cina 152
UA - Ucraina 144
DE - Germania 132
FR - Francia 92
IE - Irlanda 88
SE - Svezia 88
PL - Polonia 86
BR - Brasile 55
RU - Federazione Russa 47
HK - Hong Kong 36
FI - Finlandia 34
GB - Regno Unito 31
KR - Corea 30
CZ - Repubblica Ceca 13
BE - Belgio 11
ID - Indonesia 7
VN - Vietnam 7
JP - Giappone 6
AU - Australia 5
CH - Svizzera 5
IN - India 5
MX - Messico 4
TR - Turchia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
AT - Austria 3
NL - Olanda 3
CA - Canada 2
EU - Europa 2
KG - Kirghizistan 2
NP - Nepal 2
SA - Arabia Saudita 2
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KZ - Kazakistan 1
MN - Mongolia 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
TW - Taiwan 1
UZ - Uzbekistan 1
VA - Santa Sede (Città del Vaticano) 1
Totale 12.300
Città #
Woodbridge 3.207
Wilmington 2.823
Houston 2.497
Fairfield 364
Chandler 268
Ann Arbor 221
Singapore 195
Ashburn 159
Seattle 137
Cambridge 116
Jacksonville 116
Kraków 85
Dublin 83
Rome 77
Medford 63
Dearborn 62
New York 61
Zhengzhou 47
Beijing 43
Hong Kong 35
Santa Clara 35
Milan 33
Lawrence 29
Menlo Park 20
San Diego 18
The Dalles 18
Council Bluffs 15
Boardman 14
Palo Alto 14
San Francisco 13
Mülheim 12
Shanghai 12
Brussels 11
Nanjing 11
Phoenix 10
Verona 10
Moscow 9
Munich 9
Creede 8
Falls Church 8
Brno 7
Jakarta 7
Nuremberg 7
Dong Ket 6
Hefei 6
London 6
Olomouc 6
São Paulo 6
Helsinki 5
Kunming 5
Los Angeles 5
Redwood City 5
University Park 5
Nanchang 4
Auburn Hills 3
Chengdu 3
Colorado Springs 3
Guangzhou 3
Jinan 3
Lausanne 3
Mountain View 3
Ankara 2
Anápolis 2
Araraquara 2
Arezzo 2
Bagnoregio 2
Belo Horizonte 2
Binasco 2
Canberra 2
Caxias do Sul 2
Engelhard 2
Fuzhou 2
Guadalupe 2
Guiyang 2
Göttingen 2
Juiz de Fora 2
Monte Vista 2
Novokuznetsk 2
Redmond 2
Riyadh 2
Roebling 2
San Jose 2
Zurich 2
Almaty 1
Alta Floresta 1
Amman 1
Ampang 1
Amsterdam 1
Apo 1
Avellino 1
Baghdad 1
Bangalore 1
Baotou 1
Bari 1
Bobrynets 1
Brasília 1
Buenos Aires 1
Buffalo 1
Cabo Frio 1
Cachoeirinha 1
Totale 11.130
Nome #
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 520
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice 462
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 450
Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms. 444
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance. 442
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 438
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection 435
Characterization of drug-resistance mutations in HBV D-genotype chronically infected patients, naïve to antiviral drugs. 434
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 428
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 427
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 426
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. 423
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 415
Specific HbsAg genetic determinants are associated with occult HBV infection in vivo and HbsAg detection 412
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 409
Multidrug resistance after lamivudine therapy for chronic hepatitis B 408
HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb 405
Optimal efficacy of interferon-free HCV retreatment after protease inhibitors failure in real life. 400
Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance 386
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 385
Aciclovir, herpes viruses and HIV: a never-ending story 381
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. 376
Novel reverse transcriptase mutations specifically associated with selected anti-Hbv treatment can induce alterations and stop-codons in Hbv S antigen 369
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 368
Two-year surveillance on fluconazole susceptibility of Candida spp isolates in a general and university hospital in Rome. 364
Interstitial pulmonary fibrosis in chronic HCV hepatitis treated with interferon 357
Long-term intramuscular teicoplanin treatment of chronic osteomyelitis due to oxacillin-resistant Staphylococcus aureus in outpatients 338
High rates of chronic HBV genotype E infection in a group of migrants in Italy from West Africa: Virological characteristics associated with poor immune clearance 337
Epidemiological burden estimates for pathologies with a non constant risk: an application to HCV in Italy according to age, Metavir score, and genotype 330
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection 318
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 249
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 41
Evaluation of the antibody response to EBNA-1 in EBV infections | VALIDITA DELLA RICERCA DEGLI ANTICORPI ANTI EBNA-1 NELLA DIAGNOSTICA DELLE INFEZIONI DA EBV 27
Therapy and prevention of infective endocarditis 18
Totale 12.422
Categoria #
all - tutte 24.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020665 0 0 0 0 0 0 0 0 0 252 189 224
2020/20211.798 207 212 215 227 171 204 221 173 35 50 64 19
2021/2022441 24 36 36 22 4 32 21 13 103 33 15 102
2022/2023608 54 65 54 92 41 118 35 54 51 7 25 12
2023/2024200 31 2 11 4 6 66 0 14 4 8 0 54
2024/2025646 24 170 95 44 48 30 61 34 121 19 0 0
Totale 12.422